期刊文献+

某三甲妇儿医院2016年来曲唑门诊超说明书用药回顾性调查分析 被引量:7

Retrospective evaluation of letrozole off label use in outpatients in a tertiary maternity and child hospital
原文传递
导出
摘要 目的:了解某三甲妇儿医院门诊来曲唑超说明书用药现状,为规范医疗机构超说明书用药管理。方法:通过医院信息系统收集来曲唑处方,制定标准,按标准分析处方中超说明书用药情况。结果:共汇门诊来曲唑处方3 451张,超说明书用药处方2 937张,来曲唑超说明书用药的发生率为85.11%;超说明书用药类型为超适应证用药和超剂量用药;超适应证用药前3的疾病诊断为女性不孕症、女性原发性不育症、女性继发性不育症;年龄、性别、处方开具科室均是超说明书用药的风险因素。结论:某三甲妇儿医院2016年门诊来曲唑超说明书用药情况普遍,需对来曲唑超说明书用药进行规范管理,保障来曲唑的用药安全和规避相关医疗风险。 OBJECTIVE To investigate and standardize the management of off label use of letrozole in our hospital.METHODS The standard was set up to analyze off label use of letrozole in prescriptions collected from the hospital system.RESULTS Totally 3 451 letrozole prescriptions were collected,including 2 937 off label prescriptions,accounting for85.11%.Major types of off label use were beyond indications and wrong dosage.The top 3 off-label indications were female infertility,female primary infertility and female secondary infertility.Risk factors of off label use were age,gender and prescribing departments.CONCLUSION Off label use of letrozole is common and needs to be standardized in our hospital to guarantee drug safety and avoid medical risk.
出处 《中国医院药学杂志》 CAS 北大核心 2017年第24期2486-2489,共4页 Chinese Journal of Hospital Pharmacy
基金 厦门市科学技术局科技计划项目(编号:3502Z20154032)
关键词 来曲唑 超说明书用药 门诊 用药安全 letrozole off label use outpatient drug safety
  • 相关文献

参考文献12

二级参考文献127

  • 1周金培,朱凤军,黄文龙.抗癌药来曲唑的合成研究[J].中国药科大学学报,2003,34(4):375-376. 被引量:21
  • 2章汉旺,李莉,李清,邓彧,段秀娟.来曲唑和克罗米酚对小鼠着床期子宫内膜容受性的影响[J].生殖与避孕,2007,27(4):251-254. 被引量:27
  • 3杜敏联.中枢性(真性)性早熟诊治指南[J].中华儿科杂志,2007,45(6):426-427. 被引量:304
  • 4Cole PA, Robinson CH. Mechanism and inhibition of cytochrome P-450 aromatase. J Med Chem, 1990, 33 (11):2 933-42.
  • 5Sinha S, Kaseta J, Santner SJ, et al. Effect of CGS 20 267 on ovarian aromatase and gonadotropin levels in the rat. Breast Cancer Res Treat, 1998, 48(1):45-51.
  • 6Mitwally MF, Casper RF. Potential of aromatase inhibitors for ovulation and superovulation induction in infertile women. Drugs, 2006, 66(17):2 149-60.
  • 7Attar E, Bulun SE. Aromatase inhibitors: the next generation of therapeutics for endometriosis? Fertil Steril, 2006, 85 (5):1 307-18.
  • 8Haynes BP, Dowsett M, Miller WR, et al. The pharmacology of letrozole. J Steroid Biochem Mol Biol, 2003, 87(1):35-45.
  • 9Jonat W, Hilpert F, Kaufmann M. Aromatase inhibitors a safety comparison Expert Opin Drug Saf, 2007, 6(2): 165-74.
  • 10Bajetta E, Zilembo N, Dowsett M, et al. Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients.Eur J Cancer, 1999, 35(2):208-13.

共引文献853

同被引文献72

引证文献7

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部